APS Pharmacy
503A sterile compounding pharmacy in Palm Harbor, Florida, operating as Drug Depot, Inc. Named publicly by . What is checkable, and how to check it.
Updated 2026-09-18
How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.
APS Pharmacy is 503A sterile compounding pharmacy in Palm Harbor, Florida, operating as Drug Depot, Inc.
No provider we review names this pharmacy publicly. It appears here because it is widely reported as supplying compounded GLP-1s and because it has a published FDA record worth being able to look up — you may well be dispensed from it without ever being told.
What we can verify about APS Pharmacy
| APS Pharmacy | |
|---|---|
| Facility type | 503A |
| Location | Palm Harbor, Florida |
| Accreditation | Described in industry roundups as PCAB accredited |
| Named publicly by | No provider we review names it |
| FDA actions published | Yes — 7 entries |
- Operates as Drug Depot, Inc. and is listed by FDA as a 503A facility.
- Industry roundups describe it as PCAB-accredited with sterile compounding cleanrooms and environmental monitoring beyond USP 797 minimums.
- FDA issued a press release in April 2022 alerting customers to a voluntary recall of compounded drugs due to sterility issues by Drug Depot, LLC, dba APS Pharmacy.
- A warning letter was issued in March 2023 and closed out by FDA in October 2023.
That is the complete list of what we could confirm from published sources as of 2026-09-18. We have not filled the gaps with inference — if something is not above, we could not verify it.
Our read
APS is the clearest example on this site of why you should not take a published ranking at face value. It appears in industry roundups praised specifically for its safety focus and environmental monitoring — and its FDA record contains a 2022 recall for sterility issues serious enough that FDA issued a press release about it. Both things are true. The recall was voluntary, the later warning letter was closed out in 2023, and an older 2019 letter was also closed out, which means FDA confirmed resolution in each case. But anyone recommending this pharmacy on its safety record owes you the whole record.
Who dispenses from it
No provider in our roster names this pharmacy publicly, so we cannot tell you who uses it. That is the normal situation in this market and it is the reason these pages exist — ask your provider directly which pharmacy fills your prescription, and check the answer against the FDA list below.
Being named by a provider does not mean that provider uses it exclusively, or that it will fill your particular prescription. Multi-pharmacy networks route by state and by product, so confirm which pharmacy serves you specifically.
FDA enforcement record
FDA publishes inspections, recalls and other actions for compounders. The entry below is quoted from that list as FDA states it. Read the glossary before drawing conclusions — most of these documents are not what people assume.
Listed as: Drug Depot Inc. (dba APS Pharmacy), Palm Harbor, FL — 503A Facility
- State Referral Letter Issued 10/11/2023
- FMD-145 Issued 10/11/2023
- Warning Letter Closeout Issued 10/11/2023
- Warning Letter (03/31/2023)
- 483 Issued 06/17/2022
- FDA Press Release: FDA alerts customers to voluntary recall of compounded drugs due to sterility issues by Drug Depot, LLC, dba APS Pharmacy (04/26/2022)
- Warning Letter Closeout Issued 09/20/2019
Our note. Both warning letters in this record carry close-outs, meaning FDA confirmed the issues were resolved. The 2022 recall was voluntary. We are reporting the record, not alleging a current problem.
Worth knowing. How to read this fairly. A Form 483 records inspection observations, not proven violations, and a busy facility that FDA visits often will collect more of them than one nobody inspects. Absence from the list is not a clean bill of health — it can simply mean no inspection or no published action. And the legal entity matters: similarly-named companies are frequently different facilities with different records.
- Form 483 — a list of observations an investigator made during an inspection. It is not a finding of violation and not a penalty. Large, frequently-inspected facilities accumulate them.
- Warning Letter — more serious. FDA alleging significant violations and requiring a response.
- Warning Letter Close Out — FDA confirming the issues in a warning letter were resolved. When you see one, read it alongside the letter it closes.
- Untitled Letter — below the threshold of a warning letter; concerns raised without the same formal weight.
- FMD-145 Letter — correspondence about a facility’s registration or compounding status.
- State Referral Letter — FDA passing a matter to the state board of pharmacy.
Source: FDA, Compounding: Inspections, Recalls, and other Actions. Checked 2026-09-18. FDA updates this list, so confirm the current position before relying on it.
How to verify APS Pharmacy yourself
- Ask your provider, in writing, to confirm this is the pharmacy filling your prescription and whether it is a 503A pharmacy or a registered 503B outsourcing facility.
- Look the pharmacy up on the state board of pharmacy website for the state it operates from. Boards publish public licence lookup tools, and licences are public records.
- Check whether it holds voluntary accreditation. PCAB accreditation is administered through ACHC, which publishes an accredited-organisation search; NABP runs its own three-year Compounding Pharmacy Accreditation and provides a form for checking status.
- Ask for a certificate of analysis for your batch. Most will not offer one unprompted; the response you get is informative either way.
- If your provider will not name the pharmacy at all, that is the answer to your question — see how to spot a bad seller.
Accreditation is voluntary and its absence is not proof of a problem — plenty of properly licensed pharmacies do not carry it. Both NABP and PCAB evaluate compliance with USP standards through on-site inspection and documentation review, which is why it is a meaningful signal when present.
Where to get a GLP-1 prescription
A compounding pharmacy cannot sell you a GLP-1 directly — it fills a prescription written by a licensed clinician. So the practical route is a telehealth provider who prescribes and arranges dispensing.
Our featured provider is [Coreage Rx](/reviews/coreage-rx-tirzepatide-reviews), which prices compounded tirzepatide from $149 a month and semaglutide from $99 on the annual plan, flat at every dose and with no membership fee. That is a paid placement and we say so on every page it appears — see our disclosure. Check current pricing.
Worth knowing. An honest caveat about our own recommendation. Coreage Rx does not publish which compounding pharmacy fills its prescriptions, so we cannot tell you it uses this one or any other — and we are not going to imply it. If pharmacy provenance is your priority, the providers that do name their pharmacies are listed on how to spot a bad seller. Ask any provider the question directly and get the answer in writing.
Common questions
Can I buy from APS Pharmacy directly?
No. A compounding pharmacy dispenses against a prescription from a licensed clinician — it is not a shop. Anyone offering to sell you a compounded GLP-1 without a prescription is not operating legally, whatever pharmacy name is attached.
Does a named pharmacy mean the medication is FDA-approved?
No, and this is the distinction that matters most. A compounded preparation is not FDA-approved regardless of how well-regarded the pharmacy is. The pharmacy is licensed and may be accredited; the preparation itself has not been reviewed by the FDA for safety, effectiveness or manufacturing quality.
What is 503A, briefly?
A 503A pharmacy compounds for an individual patient against a specific prescription and is regulated primarily by state boards of pharmacy. A 503B outsourcing facility can produce larger batches, registers with the FDA and is subject to FDA inspection. Full explanation in is compounded GLP-1 still legal.
Verified 2026-09-18 from published sources. We are not affiliated with APS Pharmacy and this is not an endorsement of any particular pharmacy — it is a record of what is publicly checkable.
Read next
- The pharmacies behind the prescriptions
The pharmacy is the part that is actually regulated — and most providers will not name theirs. Here are the ones that have been named publicly.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- Coreage Rx tirzepatide review
Best overall on true monthly cost. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $199 a month.